Filing Details

Accession Number:
0001209191-17-048459
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-10 17:47:55
Reporting Period:
2017-08-04
Filing Date:
2017-08-10
Accepted Time:
2017-08-10 17:47:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1346830 Cara Therapeutics Inc. CARA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1597152 Ph.d. Frederique Menzaghi C/O Cara Therapeutics, Inc.
107 Elm Street, 9Th Floor
Stamford CT 06902
Vp-Research & Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-08-04 3,000 $15.00 117,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2017.